Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma

Head and Neck

Volumn 35, Issue 2, 2013, Pages 190-194

  Ch'ng, Sydney ^a   Clark, Jonathan R ^a   Brunner, Markus ^a   Palme, Carsten E ^b   Morgan, Gary J ^b   Veness, Michael J ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cutaneous squamous cell carcinoma; staging; tumor differentiation; tumor factor

Indexed keywords

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; DISEASE SPECIFIC SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; SKIN CARCINOMA; THICKNESS; TUMOR DIFFERENTIATION;

AGE FACTORS; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEW SOUTH WALES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84872807551     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22941     Document Type: Article

References (15)

1. Farasat S, Yu SS, Neel VA, et al. A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011; 64: 1051 - 1059.
2. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A,. American Joint Committee on Cancer (AJCC) Staging Manual. 7th ed. New York: Springer; 2009.
3. de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW,. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005; 152: 481 -488.
4. Veness MJ, Porceddu S, Palme CE, Morgan GJ,. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621 -631.
5. Veness MJ, Palme CE, Morgan GJ,. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006; 106: 2389 -2396.
6. Veness MJ,. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol 2007; 2007: 80572.
7. Veness MJ, Porceddu S, Palme CE, Morgan GJ,. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621 -631.
8. Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST,. Parotid metastasis-an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 2006; 59: 1288 -1293.
9. Ch'ng S, Maitra A, Allison RS, et al. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008; 98: 101 -105.
10. Rowe DE, Carroll RJ, Day CL Jr,. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976 -990.
11. Lohmann CM, Solomon AR,. Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol 2001; 8: 27 -36.
12. Jackson JE, Dickie GJ, Wiltshire KL, et al. Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach. Head Neck 2009; 31: 604 -610.
13. Ross AS, Whalen FM, Elenitsas R, Xu X, Troxel AB, Schmults CD,. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg 2009; 35: 1859 -1866.
14. Mendenhall WM, Amdur RJ, Williams LS, Mancuso AA, Stringer SP, Price Mendenhall N,. Carcinoma of the skin of the head and neck with perineural invasion. Head Neck 2002; 24: 78 -83.
15. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115: 1883 -1891.